Novartis

6 Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part II

6 Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part II

Motley Fool

Second FDA thumbs-up for Novartis Ilaris

Second FDA thumbs-up for Novartis Ilaris

Pharma Times, UK

3 Bio Companies Facing The Patent Cliff

3 Bio Companies Facing The Patent Cliff

Seeking Alpha

Small Companies Are Leading Innovation For New Drugs To Treat Depression

Small Companies Are Leading Innovation For New Drugs To Treat Depression

Forbes

Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players

Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players

Motley Fool

Novartis Boost Seen in Fast Approvals as Protection Ends

Novartis Boost Seen in Fast Approvals as Protection Ends

Bloomberg

Novartis Unloads OTC Products Made At Troubled Nebraska Plant

Novartis Unloads OTC Products Made At Troubled Nebraska Plant

Pharmalot

Novartis
OTC

Big Pharma's Kickback Conundrum

Big Pharma's Kickback Conundrum

Motley Fool

Novartis Rebuts Government Allegations of Misconduct

Novartis Rebuts Government Allegations of Misconduct

Motley Fool